• 1 Year Returns: 7.70%
• 3 Year Returns: 13.22%
• 5 Year Returns: 6.24%

• Pharmaceuticals | 74.19%
• Labs & Life Sciences Services | 21.10%
• Miscellaneous | 2.30%
• Others | 1.64%
• Diversified Chemicals | 0.78%

• Torrent Pharmaceuticals Ltd | 9.94%
• Sun Pharmaceutical Industries Ltd | 9.75%
• Apollo Hospitals Enterprise Limited | 7.08%
• Cipla Ltd | 4.56%
• Aurobindo Pharma Ltd | 4.29%

• Equity | 97.61%
• Cash & Equivalents | 2.39%

The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW) is 5.66

Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW) is 11.75

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW) is 0.88

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW) is 0.10

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.